All In Biotech

Drug Trial Radar · NCT01547741

Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

A Phase III Clinical Trial Comparing the Combination of Docetaxel Plus Cyclophosphamide to Anthracycline-Based Chemotherapy Regimens for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

Last checked: Nov 19, 2026Latest source record: Aug 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 4,242 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

4,242

Actual

Start

Apr 2012

Primary completion

May 31, 2022

Study completion Oct 17, 2025

Sponsor

Lead sponsor
NSABP Foundation IncResearch network
Sponsor type
Research network
Collaborators
National Cancer Institute (NCI)
First posted
Mar 8, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of breast cancer cells, either by killing the cells or by stopping them from dividing. Giving the drugs in different combinations may kill more breast cancer cells. Giving combination chemotherapy after surgery may kill any tumor cells that remain after surgery. PURPOSE: This randomized phase III trial is studying different combination chemotherapy regimens and their side effects and comparing how well they work in treating women with non-metastatic breast cancer.

Conditions

  • Breast Cancer

Interventions

  • DoxorubicinDrug

  • CyclophosphamideDrug

  • DocetaxelDrug

  • PaclitaxelDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Invasive Disease-free Survival (IDFS)Time frame: Assessed before each cycle of chemotherapy, 3-4 weeks after completion of chemotherapy, every 6 months through 5 years and yearly years 6-10.

Locations

915 sites in 2 countries. Site status is shown where the registry gives one.

  • Providence Alaska Medical Center

    Anchorage, Alaska

  • Arizona Oncology Associates-Biltmore Cancer Center

    Phoenix, Arizona

  • Premiere Oncology of Arizona

    Scottsdale, Arizona

  • Sedona Medical Center

    Sedona, Arizona

  • Arizona Oncology Associates

    Tucson, Arizona

  • NEA Baptist Clinic-Matthews

    Jonesboro, Arkansas

  • Kaiser Anaheim Medical Center

    Anaheim, California

  • Kaiser Permanente-Deer Valley Medical Center

    Antioch, California

  • Kaiser Permanente Medical Group - Baldwin Park

    Baldwin Park, California

  • Kaiser Foundation Hospital

    Bellflower, California

  • Providence Saint Joseph Medical Center

    Burbank, California

  • East Bay Radiation Oncology Center

    Castro Valley, California

  • Valley Medical Oncology Consultants-Castro Valley

    Castro Valley, California

  • Epic Care-Dublin

    Dublin, California

  • Northbay Cancer Center

    Fairfield, California

  • Kaiser Permanente Hospital

    Fontana, California

  • Kaiser Permanente, Fremont

    Fremont, California

  • Valley Medical Oncology Consultants-Fremont

    Fremont, California

  • Washington Hospital

    Fremont, California

  • California Cancer Center - North Fresno

    Fresno, California

  • Kaiser Permanente

    Fresno, California

  • Kaiser Permanente - Harbor City

    Harbor City, California

  • Kaiser Permanente, Hayward

    Hayward, California

  • Southern California Permanente Medical Group

    Irvine, California

  • UC San Diego Moores Cancer Center

    La Jolla, California

  • Long Beach Memorial Medical Center-Todd Cancer Institute

    Long Beach, California

  • Kaiser Permanente Los Angeles Medical Center

    Los Angeles, California

  • Kaiser Permanente

    Los Angeles, California

  • Kaiser Permanente-West Los Angeles

    Los Angeles, California

  • Cedars-Sinai Medical Center

    Los Angeles, California

  • Contra Costa Regional Medical Center

    Martinez, California

  • Memorial Medical Center

    Modesto, California

  • Kaiser Permanente-Modesto

    Modesto, California

  • Community Hospital of Monterey Peninsula

    Monterey, California

  • El Camino Hospital

    Mountain View, California

  • Highland General Hospital

    Oakland, California

  • Alta Bates Summit Medical Center - Summit Campus

    Oakland, California

  • Bay Area Breast Surgeons Inc

    Oakland, California

  • Bay Area Tumor Institute

    Oakland, California

  • Larry G Strieff MD Medical Corporation

    Oakland, California

Showing 40 of 915 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.